WHO Censorship Tactics Should be Exposed at World Health Assembly

Food and Healthcare Press Releases Tuesday May 24, 2016 13:35
GENEVA--24 May--PRNewswire/InfoQuest
  • As the Annual Summit Takes Place This Week, Global Leaders Have an Opportunity toScrutinize WHO's definition of transparency and accountability

Health Ministers from 194 countries will gather this week in Geneva to set the direction for future health policy around the world. JTI - Japan Tobacco International - is calling for the Assembly to urgently address an alarming transparency and accountability crisis at the heart of the World Health Organization (WHO) during discussions on the agency's reform.

(Logo: http://photos.prnewswire.com/prnh/20130528/617491 )

In a recent report, the WHO states that "...significant progress has been made towards meeting the objectives of being a more effective, efficient, transparent and accountable organization."[1] This contradicts censorship practices that are increasingly being witnessed at WHO meetings.

At the last Conference of the Parties (COP6) of the WHO's Framework Convention on Tobacco Control (FCTC) in 2014, members of the public and journalists were unjustifiably ejected from the public gallery, leaving them unable to observe and report on plenary sessions that are meant to be transparent. The alarming tactic of conducting proceedings behind closed doors has prompted concerns - notably by the media - that health lobbyists and non-elected parties are wielding undue influence over treaty negotiations.

These exclusion tactics go against basic transparency and accountability rules - and are in sharp contrast to other UN meetings. At the Sustainable Innovation Forum (COP21) on climate change in Paris earlier this year, some 3000 journalists were accredited, while political and business leaders from around the world actively participated in debates. Proceedings were open to the public and live-streamed on the internet. Businesses sponsored the event.

Michiel Reerink, Global Regulatory Strategy Vice-President at JTI, stated: "Nobody would argue against the need for tobacco to be appropriately regulated, but there is a right way and a wrong way of achieving that. Excluding the public and the media from debates amounts to censorship, and is unacceptable from a publicly-funded organization. This begs the question: what does the WHO have to hide?"

JTI, a member of the Japan Tobacco Group of Companies, is a leading international tobacco manufacturer. It markets world-renowned brands such as Winston, Camel, Mevius and LD. Other global brands include Benson & Hedges, Silk Cut, Sobranie and Glamour. With headquarters in Geneva, Switzerland, and about 26,000 employees worldwide, JTI has operations in more than 120 countries. Its core revenue in the fiscal year ended December 31, 2015, was USD 10.3 billion. For more information, visit http://www.jti.com.

--------------------------------------------------
1. Overview of reform implementation, World Health Organization, Report by the Director General, Sixty-ninth World Health Assembly, Provisional agenda item 11.1, March 11, 2016, p.1.
Source: JTI (Japan Tobacco International)

Latest Press Release

Walgreens Boots Alliance and Microsoft establish strategic partnership to transform health care delivery

- Companies aim to improve health outcomes and lower overall costs with enhanced digital and retail experiences and an R&D commitment to build health care solutions through seven-year agreement Walgreens Boots Alliance Inc. (WBA) and Microsoft Corp....

Ascensia Diabetes Care Announces Global Partnership With POCTech to Distribute and Co-develop Continuous Glucose Monitoring Systems

Ascensia Diabetes Care today announced it has entered into a global alliance with Zhejiang POCTech, Co., Ltd (POCTech), a developer and manufacturer of continuous glucose monitoring (CGM) systems. (Logo:...

MGI Announces Milestone of 1,000 Sequencers Installed and Opens Early Access Program for Groundbreaking Ultra-High-Throughput Sequencer, MGISEQ-T7

MGI, established in 2016 as a subsidiary of global genomics leader BGI Group, announced it has reached a new milestone of 1,000 MGI sequencers installed in 16 countries. MGI Chief Operating Officer Dr. Hui Jiang also announced the availability of MGI's...

Gift of Life Donor Program is U.S. Leader in Saving Lives

For the 11th consecutive year, Gift of Life Donor Program is the nation's leading organ procurement organization (OPO), coordinating the most life-saving organs for transplant among all 58 U.S. OPOs. Gift of Life broke two national records in 2018,...

Helsinn Group Grants Exclusive Licensing Rights to Menarini for Pracinostat

Licensing rights are worldwide excluding US, Canada, Japan and South AmericaHelsinn, a Swiss pharmaceutical group focused on building quality cancer care products, and Menarini, an Italian biopharmaceutical Group active in 136 countries worldwide, today...

Related Topics